Dengvaxia: age as surrogate for serostatus

Lancet Infect Dis. 2018 Mar;18(3):245. doi: 10.1016/S1473-3099(17)30752-1. Epub 2017 Dec 21.

Authors

Maíra Aguiar¹, Nico Stollenwerk²

Affiliations

¹ Centre for Mathematics and Applications, Faculty of Sciences and Technology, Nova University of Lisbon, 2829-516 Caparica, Portugal. Electronic address: mafsantos@fc.ul.pt.
² Centro de Matemática, Aplicações Fundamentais e Investigação Operacional, Faculdade de Ciências da Universidade de Lisboa, Lisbon, Portugal.

PMID: 29276049
DOI: 10.1016/S1473-3099(17)30752-1

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Aging*
Antibodies, Viral / blood
Dengue / prevention & control*
Dengue Vaccines / administration & dosage
Dengue Vaccines / adverse effects*
Dengue Vaccines / immunology*
Hospitalization
Humans
Immunization
Middle Aged
Safety
Serologic Tests

Substances

Antibodies, Viral
Dengue Vaccines